Two-Year Study Tracks Gender-Affirming Hormone Therapy Effects
Researchers in Leipzig will measure body composition, metabolic chamber energy use, and vascular health across 24 months of hormone treatment.
Leipzig Researchers Announce Two-Year Metabolic Follow-Up
A prospective two-year study starting in early 2027 will investigate how gender-affirming hormone therapy effects reshape resting energy expenditure and vascular health. Researchers at the LeiCeM Cluster of Excellence, Leipzig University, and the Helmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) are conducting the clinical trial. The project expands the Hormones and Health study (HHS) into a multi-year cohort.
Participants will complete clinical testing before beginning treatment and return at three, six, twelve, and twenty-four months. This longitudinal design measures the same individuals across treatment stages instead of comparing distinct demographic groups. The team plans to track how estrogen and testosterone alter body composition, blood flow, and the balance between muscle and fat.
First Phase Examines Gender-Affirming Hormone Therapy Effects
Initial findings from the first cohort showed measurable sensory shifts during early treatment. Around 40 trans men and trans women joined the initial phase of the Hormones and Health study (HHS). Researchers evaluated resting energy expenditure with a ventilated hood indirect calorimeter, while testing carotid artery function, blood clotting, eating behavior, and temperature perception.
A 2026 paper published in the journal Communications Medicine detailed results from 12 trans women and 17 trans men. Trans women treated with estrogen and a testosterone blocker showed increased sensitivity to subtle warmth and cold after three and six months. The recorded change matched baseline sensory differences previously recorded between untreated cisgender women and cisgender men.
Metabolic Chambers and Vascular Markers in the New Phase
The 2027 protocol adds whole-room indirect calorimetry to capture 24-hour energy metabolism under controlled conditions. Subjects will spend time in a metabolic chamber to record exact gas exchange. This method provides higher precision than resting ventilated hood tests.
The protocol also introduces targeted assessments of blood vessel function and vascular health markers. Investigators want to see whether exogenous testosterone alters arterial flow or elevates markers tied to vascular damage. Magnetic Resonance Imaging (MRI) scans conducted with the Max Planck Institute for Human Cognitive and Brain Sciences will track structural brain patterns across the two-year window.
Tracking Gender-Affirming Hormone Therapy Effects on Metabolic Health
Sex steroids directly regulate human energy use, tissue composition, and cardiovascular performance. Comparing participants to their own baseline eliminates genetic noise that often confounds cross-sectional metabolic studies. The data will help clinicians clarify how shifting hormone concentrations modify fat distribution and daily energy burn.
These findings can improve routine care for trans individuals while clarifying general endocrine mechanics for the wider population. The project observes human physiology during active hormonal transitions rather than relying on animal models. That setup yields direct data on how testosterone and estrogen alter human vascular tone.
Study Limitations and Clinical Interpretation
The initial findings remain preliminary and do not establish long-term clinical outcomes. Phase one relied on a small sample of roughly 40 participants, and the published sensory paper evaluated only 29 people. Larger numbers and longer observation windows are required before clinicians can draw definitive conclusions about permanent vascular or metabolic shifts.
Patients managing endocrine treatments should discuss routine metabolic panels and blood pressure monitoring with their prescribing physician rather than altering treatment based on interim data. Anyone interested in gender-affirming hormone therapy effects can review the published cohort protocol and track future releases through Leipzig University.
Related Articles
Plant and Animal Proteins Show Small Testosterone Differences in Men
A study in Finland linked higher plant protein to slightly higher testosterone, while dairy...
Read article HormonesIndoor Radon Exposure Linked to Heart Failure in Postmenopausal Women
A study in JAMA Network Open links indoor radon levels above 4 pCi/L to higher heart failure...
Read article HormonesLonger Estrogen Exposure Linked to Healthier Brain Vessels in Women
A 2026 study in Neurology links longer reproductive lifespan and hormone therapy with lower...
Read article HormonesStudy Finds Modern Hormone Therapy Does Not Raise Heart Disease Risk
A 12-year study of over 52,000 women found modern hormone replacement therapy did not raise the...
Read articleWant your hormones actually worked up?
Opt Health is a longevity-medicine practice that runs a 55+ biomarker panel — full thyroid, testosterone, estradiol, SHBG, cortisol — and reviews it one-on-one with a physician who treats hormones for a living.
See how Opt Health treats hormones →Topic updates
Get the weekly hormone optimization roundup
Testosterone, thyroid, cortisol, estrogen, menopause, perimenopause, libido, and hormone testing.
Understand Your Health Better
Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results